Wang Y, Wu H, Xin Y, Bai Y, Kong L, Tan Y, et al
Ethics declarations Funding This work was funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS120926 and R01NS127188 to S.A.G.), the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry (R01TS000344 and R01TS000327 to S.A.G.), and James and Margaret Hiller and Linda and Eric Novak (S.A.G.)
Common error: Z79.4 should NOT be assigned when insulin is given temporarily (e.g., during a hospital encounter to control blood sugar)
Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus these are the only FDA-approved semaglutide products, manufactured by Novo Nordisk